Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDI-1228-mesylate Gel in Diabetic Foot Ulcers
NCT06852976Phase 2Recruiting
- Sponsor
- Rui-Inno Pharma
- Start
- Mar 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MDI-1228 in diabetic foot ulcer (DFU), sponsored by Rui-Inno Pharma. Started Mar 2025; status: recruiting.
02
Drugs
MDI-1228
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT06852976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06852976.